Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis Nature 476 (7359), 214-219, 2011 | 3068 | 2011 |
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy V Suppiah, M Moldovan, G Ahlenstiel, T Berg, M Weltman, ML Abate, ... Nature genetics 41 (10), 1100-1104, 2009 | 2396 | 2009 |
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ... Nature genetics 45 (11), 1353-1360, 2013 | 1371 | 2013 |
Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis DR Booth, M Sunde, V Bellotti, CV Robinson, WL Hutchinson, PE Fraser, ... Nature 385 (6619), 787-793, 1997 | 1332 | 1997 |
Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study M Tunca, H Ozdogan, O Kasapcopur, F Yalcinkaya, E Tutar, R Topaloglu, ... Medicine (Baltimore) 84 (1), 1-11, 2005 | 1042 | 2005 |
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility International Multiple Sclerosis Genetics Consortium*†, ANZgene, ... Science 365 (6460), eaav7188, 2019 | 1023 | 2019 |
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci D Jager Nature genetics 41 (7), 776-782, 2009 | 1017 | 2009 |
Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis HJ Lachmann, DR Booth, SE Booth, A Bybee, JA Gilbertson, JD Gillmore, ... New England Journal of Medicine 346 (23), 1786-1791, 2002 | 789 | 2002 |
Human lysozyme gene mutations cause hereditary systemic amyloidosis MB Pepys, PN Hawkins, DR Booth, DM Vigushin, GA Tennent, AK Soutar, ... Nature 362 (6420), 553-557, 1993 | 776 | 1993 |
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 Data analysis: Bahlo Melanie 2 Brown Matthew A 6 7 Browning Brian L 20 ... Nature genetics 41 (7), 824-828, 2009 | 547 | 2009 |
Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations HJ Lachmann, B Şengül, TU Yavuzşen, DR Booth, SE Booth, A Bybee, ... Rheumatology 45 (6), 746-750, 2006 | 533 | 2006 |
Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA … E Aganna, F Martinon, PN Hawkins, JB Ross, DC Swan, DR Booth, ... Arthritis & Rheumatism 46 (9), 2445-2452, 2002 | 443 | 2002 |
Class II HLA interactions modulate genetic risk for multiple sclerosis Nature genetics 47 (10), 1107-1113, 2015 | 423 | 2015 |
Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility loci NA Patsopoulos, ... Annals of neurology 70 (6), 897-912, 2011 | 369 | 2011 |
A high-density screen for linkage in multiple sclerosis International Multiple Sclerosis Genetics Consortium The American Journal of Human Genetics 77 (3), 454-467, 2005 | 366 | 2005 |
Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever I Touitou, T Sarkisian, M Medlej‐Hashim, M Tunca, A Livneh, D Cattan, ... Arthritis & Rheumatism 56 (5), 1706-1712, 2007 | 335 | 2007 |
MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood MB Cox, MJ Cairns, KS Gandhi, AP Carroll, S Moscovis, GJ Stewart, ... PloS one 5 (8), e12132, 2010 | 307 | 2010 |
Amyloid P component. A critical review MB Pepys, DR Booth, WL Hutchinson, JR Gallimore, IM Collins, ... Amyloid 4 (4), 274-295, 1997 | 270 | 1997 |
The genetic basis of autosomal dominant familial Mediterranean fever DR Booth, JD Gillmore, HJ Lachmann, SE Booth, A Bybee, M Soytürk, ... Qjm 93 (4), 217-221, 2000 | 268 | 2000 |
Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis S Ramanathan, SW Reddel, A Henderson, JDE Parratt, M Barnett, ... Neuroimmunology & Neuroinflammation 1 (4), e40, 2014 | 249 | 2014 |